查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1993888

基因組醫療保健市場：按類型、應用、技術、組件、最終用戶、國家和地區分類－全球產業分析、市場規模、市場佔有率和預測（2026-2033 年）

Genomic Medicine Market, By Type, By Application, By Technology, By Component, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 328 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，基因組醫學市場價值將達到 359.8498 億美元，並預計從 2026 年到 2033 年將以 16.35% 的複合年成長率成長。

基因組醫學是一種現代醫療保健方法，它利用個人基因（DNA）資訊來更有效地預防、診斷和治療疾病。由於每個人都有獨特的基因組成，研究這些基因差異能夠幫助醫療專業人員了解為什麼某些個體容易患上特定疾病或對治療的反應各不相同。透過分析基因數據，醫師可以及早識別疾病風險，並為每位患者提供更合適的治療方案。這種方法有助於實現更個人化的醫療保健，尤其是在癌症治療、罕見疾病診斷和藥物選擇等領域。

從全球觀點來看，隨著世界各國政府積極推動旨在改善醫療保健成果的國家基因舉措，基因組醫學的應用正在不斷擴展。例如，英國政府支持的「英格蘭基因組學計畫」（Genomics England）實施了「十萬計劃），該計畫對約8.5萬名罕見疾病和癌症患者的10萬多個基因組進行了測序。此類政府主導的計劃正在加強基因組研究的基礎設施建設，並加速基因組技術在現代醫療保健系統中的臨床應用。

基因組學市場—市場動態

精準醫療的普及正在加速市場擴張。

精準醫療的日益普及顯著推動了基因組醫學市場的發展。這種方法強調在製定治療策略時充分考慮個體的遺傳特徵、生活方式和環境影響。基因測序和分子診斷技術的進步使醫療專業人員能夠更深入地了解疾病機制，並選擇更合適的治療方法。隨著醫療機構擴大採用個人化治療模式，對基因組分析和基因檢測的需求持續成長。此外，政府主導的基因組學相關舉措也正在推動醫療模式轉向個人化。例如，英國衛生和社會保障部透過英國國家醫療服務體系（NHS）英格蘭基因組服務中心支持基因組學項目，該中心在2023年進行了超過80萬次基因組檢測，透過支持癌症和罕見遺傳疾病的診斷，加強了基於精準醫療的醫療服務。

除了政府主導的措施外，生物技術公司也在拓展基因組學，以支持個人化醫療的研究、開發和臨床應用。例如，華大基因（BGI Genomics）報告稱，其基因組學平台已在全球範圍內處理數千萬份定序樣本，用於臨床診斷、生殖健康篩檢和疾病研究。這種大規模的基因組檢測能力有助於識別基因變異和生物標記物，使醫療專業人員和研究人員能夠開發標靶治療和個人化治療策略，從而促進精準醫療的廣泛應用。

基因組醫學市場—市場細分分析：

全球基因組學市場按類型、應用、技術、組件、最終用戶和地區進行細分。

按類型分類，診斷基因組學預計仍將是醫療保健市場的重要組成部分，因為它在識別與多種疾病相關的基因變異方面發揮著至關重要的作用。基因測序和分子診斷技術在醫療保健系統中的日益普及，提高了臨床醫生早期發現遺傳性疾病、罕見疾病和癌症的能力。診斷基因體學工具還能透過支援個人化治療策略，幫助做出更精準的臨床決策。例如，英國國家醫療服務體系 (NHS) 設立了“NHS 基因組學服務”，並將於 2024 年為患者進行超過 81 萬次基因組檢測。這其中包括針對 7000 多種罕見疾病和 200 多種癌症適應症的檢測。這種不斷擴展的臨床應用表明，診斷基因組學在改善早期診斷和支持全球精準醫療策略方面的重要性日益凸顯。

按組成部分分類，該市場可分為三大類：設備、耗材以及軟體和服務。由於耗材在定序和基因組檢測流程中持續使用，預計耗材將佔據市場的大部分佔有率。試劑、定序盒、流動池和其他耗材是所有基因組實驗和診斷測試的必需品，因此在實驗室和研究機構中需求持續強勁。例如，Illumina公司報告稱，其定序耗材在2023年的銷售額約為39億美元，這反映了其試劑和試劑盒在基因組研究和臨床診斷中的廣泛應用。這種持續的使用凸顯了耗材對於支持大規模基因組檢測和精準醫療應用的重要性。

基因組醫療保健市場—區域洞察

在全球醫療基礎設施的進步、基因組研究舉措的不斷增加以及政府鼓勵精準醫療的政策推動下，全球基因組醫學市場在多個地區呈現穩步成長。其中，北美憑藉其健全的製度框架和對基因組創新持續不斷的投資，繼續保持著重要的市場地位。政府和研究機構正積極推動基因測序、數據整合和個人化醫療方法。例如，美國國立衛生研究院（NIH）啟動了「我們所有人」（All of Us）調查計畫，旨在收集超過一百萬名參與者的健康和基因信息，以支持精準醫療研究並改進個性化醫療策略。

在北美，美國透過政府和產業界的舉措，在基因組醫學的發展中扮演著舉足輕重的角色。據美國國立衛生研究院 (NIH) 稱，在國家精準醫療舉措(NPMI) 的支持下，已從數十萬參與者中生成了基因組資料集，為疾病研究和開發提供了支持。此外，Illumina 和 Thermo Fisher Scientific 等生技公司也持續拓展基因測序技術和分子診斷解決方案。例如，Illumina 報告稱，其定序平台被用於產生全球相當一部分基因組數據，為世界各地的研究機構、醫院和國家基因組計劃提供支援。這些政府計畫和產業發展共同鞏固了美國的領先地位，並提升了北美在全球基因組醫學市場的影響力。

日本基因組醫學市場—各國概況

在日本，由於政府大力推動精準醫療和基因組研究，基因組醫學市場正穩步擴張。厚生勞動省支持一項全國性的基因組學計劃，旨在將遺傳資訊整合到臨床實踐中，尤其是在癌症診斷和治療方面。此外，日本醫療研究開發機構（AMED）持續資助旨在改善疾病預防和個人化醫療的大規模基因組研究計劃，進一步加強日本的基因組醫學生態系統。

此外，日本正在實施一系列國家基因組計劃，例如由日本醫療研究開發機構（AMED）支持的“罕見疾病和未確診疾病計劃（IRUD）”，旨在提高罕見遺傳疾病的診斷準確率。根據最新的政府計畫信息，該計劃已分析了數萬名患者的基因組數據，以支持臨床診斷和研究。同時，日本政府持續推動基因組數據的共用和先進醫療研究基礎設施的建設，可望加速基因組醫學在國內醫療體系中的普及和創新。

目錄

第1章：基因組醫學市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：基因組醫學的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：基因體醫學產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：基因組醫學市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：基因組醫學市場現狀

  • 基因組醫學市佔分析，2025年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：基因組醫學市場：依類型分類

  • 概述
    • 細分市場佔有率分析：按類型
    • 預測基因組醫學
    • 預防基因組醫學
    • 診斷基因組醫學
    • 治療性基因組醫學

第8章：基因組醫學市場：依應用領域分類

  • 概述
    • 細分市場佔有率分析：按應用
    • 腫瘤學
    • 罕見遺傳疾病
    • 感染疾病
    • 藥物基因體學
    • 其他

第9章：基因組醫學市場：依技術分類

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 次世代定序（NGS）
    • 聚合酵素鏈鎖反應（PCR）
    • 微陣列
    • 基因編輯技術

第10章：基因組醫學市場：依組成部分分類

  • 概述
    • 細分市場佔有率分析：按組成部分
    • 裝置
    • 消耗品
    • 軟體服務
    • 其他

第11章：基因組醫學市場：依最終用戶分類

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院和診所
    • 診斷檢查室
    • 研究機構
    • 製藥和生物技術公司

第12章：基因組醫學市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第13章：主要供應商分析：基因組學產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • BGI Genomics
    • Illumina
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche
    • QIAGEN
    • Agilent Technologies
    • BGI Genomics
    • Pacific Biosciences
    • Oxford Nanopore Technologies
    • Bio-Rad Laboratories
    • PerkinElmer
    • Myriad Genetics
    • Eurofins Scientific
    • Guardant Health
    • Natera
    • 23andMe, Inc.
    • Exact Sciences
    • Others

第14章：分析師的綜合視角

簡介目錄
Product Code: ANV6157

Genomic Medicine Market size was valued at US$ 35,984.98 Million in 2025, expanding at a CAGR of 16.35% from 2026 to 2033.

Genomic medicine is a modern healthcare approach that uses information from a person's genes (DNA) to help prevent, diagnose, and treat diseases more effectively. Since every individual has a unique genetic makeup, studying these genetic differences allows healthcare professionals to understand why certain people develop specific diseases or respond differently to treatments. By analyzing genetic data, doctors can identify disease risks at an early stage and provide treatments that are better suited to each patient. This approach supports more personalized healthcare, particularly in areas such as cancer treatment, rare disease diagnosis, and the selection of appropriate medications.

From a global perspective, the adoption of genomic medicine is expanding as governments promote national genome initiatives to improve healthcare outcomes. For instance, the Genomics England program, supported by the UK government, delivered the 100,000 Genomes Project, which sequenced more than 100,000 genomes from around 85,000 patients with rare diseases and cancers. These government-supported initiatives are strengthening genomic research infrastructure and accelerating the clinical integration of genomic technologies in modern healthcare systems.

Genomic Medicine Market- Market Dynamics

Growing adoption of precision medicine to accelerate market expansion

The increasing integration of precision medicine is contributing significantly to the advancement of the genomic medicine market. This approach emphasizes the development of treatment strategies that consider an individual's genetic characteristics, lifestyle patterns, and environmental influences. Progress in genomic sequencing and molecular diagnostic technologies allows healthcare professionals to gain deeper insights into disease pathways and select more appropriate therapeutic interventions. As healthcare providers increasingly adopt personalized treatment models, the demand for genomic analysis and genetic testing continues to expand. In addition, government-led genomic initiatives are supporting this transition toward individualized healthcare. For instance, the UK Department of Health and Social Care supports genomic programs through the NHS England Genomic Medicine Service, which performed over 800,000 genomic tests in 2023 to assist in diagnosing cancer and rare genetic disorders, reinforcing precision-based healthcare delivery.

In addition to government initiatives, biotechnology companies are expanding genomic technologies to support personalized medicine research and clinical adoption. For instance, BGI Genomics reported processing tens of millions of sequencing tests globally through its genomic platforms used in clinical diagnostics, reproductive health screening, and disease research. Such large-scale genomic testing capabilities support the identification of genetic variations and biomarkers, enabling healthcare providers and researchers to develop targeted therapies and individualized treatment strategies that reinforce the broader adoption of precision medicine.

Genomic Medicine Market- Segmentation Analysis:

The Global Genomic Medicine Market is segmented on the basis of Type, Application, Technology, Component, End User, and Region.

Based on Type, Diagnostic Genomic Medicine is likely to remain a key segment in the medicine market due to its critical role in identifying genetic variations associated with various diseases. The increasing adoption of genomic sequencing and molecular diagnostic technologies in healthcare systems has enhanced the ability of clinicians to detect genetic disorders, rare diseases, and cancer at an early stage. Diagnostic genomic tools also support more accurate clinical decision-making by enabling personalized treatment strategies. For instance, the NHS England established the NHS Genomic Medicine Service, which delivered over 810,000 genomic tests for patients in 2024, covering testing for more than 7,000 rare diseases and over 200 cancer indications. This expanding clinical application highlights the growing importance of diagnostic genomic medicine in improving early diagnosis and supporting precision healthcare strategies globally.

In terms of Component, this market is divided into three types: Instruments, Consumables and Software & Services. Consumables are predicted to account for a substantial portion of the market due to their continuous usage in sequencing and genomic testing workflows. Consumables such as reagents, sequencing kits, and flow cells are required for every genomic experiment or diagnostic test, creating recurring demand across laboratories and research institutions. For instance, Illumina reported that its sequencing consumables generated approximately $3.9 billion in revenue in 2023, reflecting the extensive use of reagents and kits in genomic research and clinical diagnostics. This consistent utilization highlights the importance of consumables in supporting large-scale genomic testing and precision medicine applications.

Genomic Medicine Market- Geographical Insights

The global genomic medicine market is experiencing steady expansion across several regions, supported by advancements in healthcare infrastructure, increased genomic research initiatives, and government policies encouraging precision medicine. Among these regions, North America continues to hold a significant position due to its strong institutional framework and sustained investments in genomic innovation. Government organizations and research institutions actively promote genomic sequencing, data integration, and personalized treatment approaches. For example, the National Institutes of Health introduced the All of Us Research Program, which aims to collect health and genetic information from over one million participants to support precision medicine research and improve individualized healthcare strategies.

Within North America, the United States plays a major role in advancing genomic medicine through both government and industry initiatives. According to the National Institutes of Health, genomic datasets from hundreds of thousands of participants have already been generated under national precision medicine initiatives, supporting disease research and therapeutic development. In addition, biotechnology companies such as Illumina and Thermo Fisher Scientific continue to expand genomic sequencing technologies and molecular diagnostic solutions. For example, Illumina has reported that its sequencing platforms have been used to generate the majority of the world's genomic data, supporting research laboratories, hospitals, and national genome projects worldwide. These government programs and industry developments collectively strengthen the United States' leadership and reinforce North America's influence in the global genomic medicine market.

Japan Genomic Medicine Market- Country Insights

In Japan, the genomic medicine market is steadily expanding due to strong government initiatives promoting precision healthcare and genomic research. The Ministry of Health, Labour and Welfare has supported nationwide genomic programs aimed at integrating genetic information into clinical practice, particularly in cancer diagnosis and treatment. In addition, the Japan Agency for Medical Research and Development (AMED) continues to fund large-scale genome research projects to improve disease prevention and personalized therapies, strengthening the country's genomic medicine ecosystem.

Japan has also implemented national genome initiatives such as the Initiative on Rare and Undiagnosed Diseases (IRUD), supported by AMED, to improve the diagnosis of rare genetic disorders. According to government program updates, the initiative has analyzed genomic data from tens of thousands of patients to support clinical diagnosis and research. Furthermore, the Japanese government continues to promote genomic data sharing and advanced medical research infrastructure, which is expected to enhance genomic medicine adoption and innovation within the country's healthcare system.

Genomic Medicine Market- Competitive Landscape:

Due to the continuous developments in genomic technologies and the increasing adoption of precision medicine, the global genomic medicine market is supported by the presence of both international biotechnology companies and emerging genomic solution providers, making it a extremely competitive industry. Companies offer their genomic platforms, sequencing technologies, and diagnostic solutions through direct sales channels, collaborations with healthcare institutions, research organizations, and pharmaceutical companies. Market participants compete on several factors including technological innovation, sequencing accuracy, data analysis capabilities, product reliability, and service availability. Key players such as Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN, and Agilent Technologies are focusing on strategies such as new product development, expansion of genomic research capabilities, strategic partnerships, and acquisitions to strengthen their market presence and expand their role in advancing genomic-based healthcare solutions.

Recent Developments:

In December 2025, Illumina entered into a collaboration and strategic investment agreement with MyOme to advance genomic health modeling and large-scale clinical trials using whole-genome sequencing and AI-integrated risk models. The partnership aims to enhance early disease detection and preventive healthcare strategies.

In October 2025, Thermo Fisher Scientific entered a strategic co-marketing agreement with Genovation Health and XYGene to expand access to integrated genomic testing solutions. The collaboration integrates microarray-based genomic data with clinical decision-support tools to accelerate precision medicine and pharmacogenomics applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BGI Genomics
  • Illumina
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • QIAGEN
  • Agilent Technologies
  • BGI Genomics
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Myriad Genetics
  • Eurofins Scientific
  • Guardant Health
  • Natera
  • 23andMe, Inc.
  • Exact Sciences
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Predictive Genomic Medicine
  • Preventive Genomic Medicine
  • Diagnostic Genomic Medicine
  • Therapeutic Genomic Medicine

GLOBAL GENOMIC MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Oncology
  • Rare Genetic Diseases
  • Infectious Diseases
  • Pharmacogenomics
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Gene Editing Technologies

GLOBAL GENOMIC MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Instruments
  • Consumables
  • Software & Services
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMIC MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomic Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Medicine Market Snippet by Type
    • 2.1.2. Genomic Medicine Market Snippet by Application
    • 2.1.3. Genomic Medicine Market Snippet by Technology
    • 2.1.4. Genomic Medicine Market Snippet by Component
    • 2.1.5. Genomic Medicine Market Snippet by End User
    • 2.1.6. Genomic Medicine Market Snippet by Country
    • 2.1.7. Genomic Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Medicine Key Market Trends

  • 3.1. Genomic Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Medicine Market Opportunities
  • 3.4. Genomic Medicine Market Future Trends

4. Genomic Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Medicine Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Genomic Medicine Market Landscape

  • 6.1. Genomic Medicine Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Medicine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Predictive Genomic Medicine
    • 7.1.3. Preventive Genomic Medicine
    • 7.1.4. Diagnostic Genomic Medicine
    • 7.1.5. Therapeutic Genomic Medicine

8. Genomic Medicine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Oncology
    • 8.1.3. Rare Genetic Diseases
    • 8.1.4. Infectious Diseases
    • 8.1.5. Pharmacogenomics
    • 8.1.6. Others

9. Genomic Medicine Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 9.1.2. Next-Generation Sequencing (NGS)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Microarray
    • 9.1.5. Gene Editing Technologies

10. Genomic Medicine Market - By Component

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Instruments
    • 10.1.3. Consumables
    • 10.1.4. Software & Services
    • 10.1.5. Others

11. Genomic Medicine Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Research Institutes
    • 11.1.5. Pharmaceutical & Biotechnology Companies

12. Genomic Medicine Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Genomic Medicine Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Genomic Medicine Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Genomic Medicine Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Genomic Medicine Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Genomic Medicine Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Genomic Medicine Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. BGI Genomics
    • 13.2.2. Illumina
    • 13.2.3. Thermo Fisher Scientific
    • 13.2.4. F. Hoffmann-La Roche
    • 13.2.5. QIAGEN
    • 13.2.6. Agilent Technologies
    • 13.2.7. BGI Genomics
    • 13.2.8. Pacific Biosciences
    • 13.2.9. Oxford Nanopore Technologies
    • 13.2.10. Bio-Rad Laboratories
    • 13.2.11. PerkinElmer
    • 13.2.12. Myriad Genetics
    • 13.2.13. Eurofins Scientific
    • 13.2.14. Guardant Health
    • 13.2.15. Natera
    • 13.2.16. 23andMe, Inc.
    • 13.2.17. Exact Sciences
    • 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us